Perspectives of Patients With Rheumatic Diseases in the Early Phase of COVID ‐19
Author:
Affiliation:
1. School of Clinical SciencesMonash University, and Monash Health Victoria Australia
2. Monash Health Victoria Australia
3. Royal National Hospital for Rheumatic DiseasesRoyal United Hospitals NHS Trust, and University of Bath Bath UK
Publisher
Wiley
Subject
Rheumatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.24347
Reference15 articles.
1. O'BrienJ.Coronavirus (COVID‐19) in Australia.2020URL:https://www.covid19data.com.au/.
2. COVID-19, rheumatic diseases and immunosuppressive drugs: an appeal for medication adherence
3. 178. Is Patient Uncertainty Associated with Outcomes in Systemic Lupus Erythematosus?
4. What constitutes uncertainty in systemic lupus erythematosus and rheumatoid arthritis?
5. Patient Uncertainty Questionnaire-Rheumatology (PUQ-R): development and validation of a new patient-reported outcome instrument for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) in a mixed methods study
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Psoriatic Arthritis and COVID-19: Patient Perspectives in a Large Psoriatic Arthritis Cohort;The Journal of Rheumatology;2023-09-01
2. Impact of COVID-19 on Disease Self-management Among Patients With Advanced CKD: A Qualitative Study;Kidney Medicine;2023-08
3. Effects of the COVID-19 Pandemic in Unvaccinated Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients Using Disease-modifying Antirheumatic Drugs;Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy;2023-06-23
4. The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database;European Journal of Rheumatology;2023-01-17
5. A scoping review of non-professional medication practices and medication safety outcomes during public health emergencies;Public Health;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3